4.7 Article

Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15

期刊

KIDNEY INTERNATIONAL
卷 79, 期 9, 页码 987-996

出版社

ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2010.539

关键词

5/6 nephrectomy; ketoacids; KLF15; protein restriction

资金

  1. Shanghai Leading Academic Discipline Project [B902]
  2. Shanghai Technology and Science Committee [08dz1900600]
  3. NIH [R01-AG027628, R01-DK080742, R01HL084154]
  4. Chinese Natural Science Foundation [81070272]

向作者/读者索取更多资源

Dietary protein restriction is an important treatment for chronic kidney disease. Herein, we tested the effect of low-protein or low-protein plus ketoacids (KA) diet in a remnant kidney model. Rats with a remnant kidney were randomized to receive normal protein diet (22%), low-protein (6%) diet (LPD), or low-protein (5%) plus KA (1%) diet for 6 months. Protein restriction prevented proteinuria, decreased blood urea nitrogen levels, and renal lesions; however, the LPD retarded growth and decreased serum albumin levels. Supplementation with KA corrected these abnormalities and provided superior renal protection compared with protein restriction alone. The levels of Kruppel-like factor-15 (KLF15), a transcription factor shown to reduce cardiac fibrosis, were decreased in remnant kidneys. Protein restriction, which increased KLF15 levels in the normal kidney, partially recovered the levels of KLF15 in remnant kidney. The expression of KLF15 in mesangial cells was repressed by oxidative stress, transforming growth factor-beta, and tumor necrosis factor (TNF)-alpha. The suppressive effect of TNF-alpha on KLF15 expression was mediated by TNF receptor-1 and nuclear factor-kappa B. Overexpression of KLF15 in mesangial and HEK293 cells significantly decreased fibronectin and type IV collagen mRNA levels. Furthermore, KLF15 knockout mice developed glomerulosclerosis following uninephrectomy. Thus, KLF15 may be an antifibrotic factor in the kidney, and its decreased expression may contribute to the progression of kidney disease. Kidney International (2011) 79, 987-996; doi:10.1038/ki.2010.539; published online 19 January 2011

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Medicine, General & Internal

A young patient with back pain

Massimo Torreggiani, Vittoria Esposito, Ciro Esposito

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)

Article Multidisciplinary Sciences

Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice

Fabrizio Grosjean, Elena M. Yubero-Serrano, Feng Zheng, Vittoria Esposito, Shobha Swamy, Sharon J. Elliot, Weijing Cai, Helen Vlassara, Fadi Salem, Gary E. Striker

PLOS ONE (2018)

Article Urology & Nephrology

Consecutive episodes of heart and kidney failure in an otherwise healthy young man

V. Esposito, D. Catucci, M. Colucci, M. Torreggiani, F. Grosjean, C. Esposito

BMC NEPHROLOGY (2019)

Article Peripheral Vascular Disease

Smart Flow for the evaluation of the hemodialysis arteriovenous fistula

Marco Colucci, Massimo Torreggiani, Irene Bernardi, Simone Stangalino, Davide Catucci, Vittoria Esposito, Giuseppe Sileno, Ciro Esposito

JOURNAL OF VASCULAR ACCESS (2020)

Editorial Material Urology & Nephrology

Smile! (Life will be better)

Vittoria Esposito, Giuseppe Sileno, Silvio Abati, Marco Colucci, Massimo Torreggiani, Fabrizio Grosjean, Ciro Esposito

JOURNAL OF NEPHROLOGY (2020)

Article Urology & Nephrology

Don't judge the book by its cover horizontal ellipsis ...

Ettore Pasquinucci, Vittoria Esposito, Giuseppe Sileno, Marco Colucci, Marta Arazzi, Ciro Esposito

JOURNAL OF NEPHROLOGY (2021)

Article Physiology

Outcomes in Living Donor Kidney Transplantation: The Role of Donor's Kidney Function

Massimo Torreggiani, Ciro Esposito, Elena Martinelli, Thomas Jouve, Antoine Chatrenet, Lionel Rostaing, Marco Colucci, Ettore Pasquinucci, Giuseppe Sileno, Vittoria Esposito, Giorgina B. Piccoli, Paolo Malvezzi

Summary: Donor's eGFR and age are strong predictors of recipient's kidney function at 3 years post transplant, suggesting that donor eGFR should be carefully considered along with other factors, especially age.

KIDNEY & BLOOD PRESSURE RESEARCH (2021)

Article Urology & Nephrology

COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France

Sophie Blanchi, Massimo Torreggiani, Antoine Chatrenet, Antioco Fois, Beatrice Maze, Linda Njandjo, Giovanna Bianco, Nicola Lepori, Alessio Pili, Pierre-Antoine Michel, Giuseppe Sileno, Marta Arazzi, Vittoria Esposito, Antonello Pani, Elisabetta Versino, Ciro Esposito, Hafedh Fessi, Gianfranca Cabiddu, Giorgina Barbara Piccoli

Summary: HDPs showed hesitancy towards COVID-19 vaccination due to concerns about side effects and vaccine efficacy, especially among younger patients with lower perception of disease severity. Trust in scientists and previous experience with influenza vaccination were associated with a more positive attitude towards COVID-19 vaccination.

KIDNEY INTERNATIONAL REPORTS (2021)

Article Multidisciplinary Sciences

The role of kidney dysfunction in COVID-19 and the influence of age

Edoardo La Porta, Paola Baiardi, Lorenzo Fassina, Alessandro Faragli, Simone Perna, Federico Tovagliari, Ilaria Tallone, Giuseppina Talamo, Giovanni Secondo, Giovanni Mazzarello, Vittoria Esposito, Matteo Pasini, Francesca Lupo, Giacomo Deferrari, Matteo Bassetti, Ciro Esposito

Summary: COVID-19 patients often experience acute kidney injury (AKI), which is associated with mortality and severity. However, the role of kidney dysfunction in COVID-19 is still debated. This retrospective study investigated the impact of kidney dysfunction on COVID-19 severity and mortality in a cohort of hospitalized patients. The study also examined the relationship between kidney function, age, and COVID-19 progression, using different equations to estimate glomerular filtration rate (GFR). Logistic regressions and predictive analysis were performed, and accurate predictions for AKI and mortality were achieved.

SCIENTIFIC REPORTS (2022)

Meeting Abstract Transplantation

SALT AND CHRONIC KIDNEY DISEASE: HOW MUCH DOES THE PATIENT KNOW? A PILOT STUDY

Marco Colucci, Roberta Gobbi, Gabriella Adamo, Ettore Pasquinucci, Giuseppe Sileno, Marta Arazzi, Vittoria Esposito, Ciro Esposito

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Meeting Abstract Transplantation

DETERMINANTS OF LENGHT OF HOSPITAL STAY (LOS) IN NEPHROTIC SYNDROME PATIENTS

Simone Accarino, Marco Colucci, Ettore Pasquinucci, Giuseppe Sileno, Vittoria Esposito, Marta Arazzi, Eleonora Cristini, Ciro Esposito

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Meeting Abstract Transplantation

KIDNEY BIOPSY IN DIABETIC PATIENTS ALLOWS A BETTER DEFINITION OF DIAGNOSIS AND OUTCOME

Vittoria Esposito, Yasser Ode, Ettore Pasquinucci, Massimo Torreggiani, Luca Semeraro, Giuseppe Sileno, Marco Colucci, Ciro Esposito

NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)

Meeting Abstract Transplantation

DETERMINANTS OF SERUM POTASSIUM IN HEMODIALYSIS PATIENTS. DOES JUST ONE COUNT?

Giuseppe Sileno, Silvia Brazzo, Paola Baiardi, Massimo Torreggiani, Vittoria Esposito, Marco Colucci, Ettore Pasquinucci, Giuseppe Locatelli, Chiara Morelli, Ciro Esposito

NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)

Meeting Abstract Transplantation

ETELCALCETIDE AND CINACALCET TREATMENT IN HEMODYALISED PATIENTS: A RETROSPECTIVE, SINGLECENTER STUDY

Alice Mariotto, Emanuela Efficace, Odeh Yasser, Giuseppe Locatelli, Davide Catucci, Vittoria Esposito, Massimo Torreggiani, Ciro Esposito

NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)

Meeting Abstract Transplantation

RISKS AND BENEFITS OF ORAL ANTICOAGULATION THERAPY IN HEMODIALYSIS PATIENTS

Giuseppe Sileno, Alice Guerini, Massimo Torreggiani, Marco Colucci, Grazia Bonelli, Davide Catucci, Vittoria Esposito, Alice Mariotto, Ciro Esposito

NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)

暂无数据